PRESS RELEASE published on 03/11/2024 at 08:00, 1 year 11 months ago Guerbet renforce son comité exécutif avec deux nouvelles nominations pour consolider son ambition à moyen et long terme. Guerbet renforce son comité exécutif avec deux nouvelles nominations pour consolider son ambition à moyen et long terme. Christine Allard et Eva Ohlsson rejoignent le comité exécutif de Guerbet en tant que Directrice des Affaires Publiques et Communication, et Directrice Ressources Humaines Innovation Comité Exécutif Nominations Guerbet Ambition
PRESS RELEASE published on 02/08/2024 at 17:45, 2 years ago Guerbet: Chiffre d’affaires 2023 Guerbet publie son chiffre d’affaires annuel: 785,7 M€, en hausse de 6,4% à TCC. Objectifs 2024: croissance attendue supérieure à 8% à périmètre constant et TCC. Taux de marge d’EBITDA retraité supérieur à 11% Croissance Chiffre D’affaires Guerbet Imagerie Médicale EBITDA Retraité
PRESS RELEASE published on 02/08/2024 at 17:45, 2 years ago Guerbet: 2023 revenue Guerbet reports 2023 revenue growth of 6.4% at constant exchange rates, with an anticipated 2024 revenue growth of over 8%. Restated EBITDA margin exceeds initial 11% target, while 2024 profitability target remains at 14.4% 2024 Guidance Guerbet Medical Imaging 2023 Revenue Restated EBITDA Margin
PRESS RELEASE published on 01/30/2024 at 17:45, 2 years ago Guerbet: Death of Michel Guerbet, son of the founder and company director for over 30 years. Guerbet announces the passing of Michel Guerbet, son of the founder, and company director for over 30 years. The Group pays tribute to his exceptional leadership and significant contributions to the company's development Guerbet Michel Guerbet Company Director Medical Imaging Pharmaceutical Products
PRESS RELEASE published on 01/30/2024 at 17:45, 2 years ago Guerbet: Décès de Michel Guerbet, fils du fondateur et dirigeant de l’entreprise durant plus de 30 ans. Décès de Michel Guerbet, fils du fondateur et dirigeant de l’entreprise Guerbet pendant plus de 30 ans. L'entreprise rend hommage à sa contribution exceptionnelle à son développement. Guerbet, imagerie médicale, innovateur, R&D, actionnariat familial R&D Guerbet Imagerie Médicale Innovateur Actionnariat Familial
PRESS RELEASE published on 01/11/2023 at 18:23, 3 years 1 month ago Guerbet: Intrasense opens its share capital to the Guerbet Group, which announces its intent to file a voluntary tender offer under the same price conditions
PRESS RELEASE published on 01/11/2023 at 18:23, 3 years 1 month ago Guerbet: Intrasense ouvre son capital au groupe Guerbet, qui annonce son intention de déposer un projet d’offre publique d’achat volontaire dans les mêmes conditions de prix
PRESS RELEASE published on 01/11/2023 at 10:57, 3 years 1 month ago Guerbet: Bilan semestriel du contrat de liquidité
Published on 02/20/2026 at 20:15, 1 hour 29 minutes ago Lithium South Announces Results of its Annual and Special Meeting of Securityholders
Published on 02/20/2026 at 20:15, 1 hour 29 minutes ago Verdera Energy Announces Closing of Qualifying Transaction
Published on 02/20/2026 at 18:30, 3 hours 14 minutes ago Sparta Updates Delay in Filing Annual Financial Statements
Published on 02/20/2026 at 15:45, 5 hours 59 minutes ago Revolve Announces Closing of Initial US$10 Million Advance on Strategic Financing With Callaway
Published on 02/20/2026 at 14:30, 7 hours 14 minutes ago Norse Gold Announces Application for Reactivation to TSX-V, Private Placement Financing and Stock Options Grant
Published on 02/20/2026 at 18:36, 3 hours 7 minutes ago EQS-Adhoc: innoscripta SE: Management Board Proposes Dividend of EUR 4.00 per Share
Published on 02/20/2026 at 18:31, 3 hours 12 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 02/20/2026 at 18:00, 3 hours 43 minutes ago Leclanché conclut un accord de financement d’un montant de CHF 16,7 millions pour soutenir ses opérations à court terme
Published on 02/20/2026 at 18:00, 3 hours 43 minutes ago Leclanché Secures Financing Arrangement in the amount of CHF 16.7 million to Support Near-Term Operations
Published on 02/20/2026 at 19:29, 2 hours 14 minutes ago SFPI GROUP: Liquidity agreement report S2 2025
Published on 02/20/2026 at 19:29, 2 hours 14 minutes ago SFPI GROUP: bilan du contrat de liquidité S2 S025
Published on 02/20/2026 at 18:00, 3 hours 44 minutes ago TERACT - Résiliation du contrat de liquidité